Articles tagged "Living-related liver donors"

2016 American Transplant Congress
Opioid-Sparing Pain Management Improves Outcomes and Safety in Living Liver Donors.
D. Ladner,¹ E. Pomfret,² M. Simpson,² J. Guarrera,³ R. Fisher,⁴ A. Skaro,¹ T. Baker,¹ T. Curtis,¹ A. Daud,¹ B. Platt,¹ R. Kang,¹ N. Salehitezangi,¹ J. Holl,¹ M. Abecassis,¹ D. Woods.¹
¹Northwestern University, Chicago, IL; ²Lahey Clinic, Burlington, MA; ³Columbia University, New York, NY; ⁴Virginia Commonwealth Univeristy, Richmond, VA.
BACKGROUND: As part of the ancillary four center study, to the Adult-to-Adult Living Donor Liver Transplant Cohort Study (A2ALL), over 75% of living liver donors…
2016 American Transplant Congress
Evolution of Donor Nephrectomy: Long-Term Outcomes with Four Different Techniques Between 1963 and 2014 at a Single Institution.
O. Serrano,¹ A. Bangdiwala,² D. Vock,³ E. Minja,¹ A. Pugalendhi,¹ K. Yadav,¹ V. Kirchner,¹ W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ E. Finger,¹ T. Pruett,¹ A. Matas,¹ R. Kandaswamy.¹
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics and Bioinformatics Core, Masonic Cancer Center, Minneapolis, MN; ³Biostatistics, Univ. of Minnesota, Minneapolis, MN.
PURPOSE: The development of minimally-invasive approaches to donor nephrectomy (DN) has been primarily driven by the potential advantages it presents the donor. Questions remain over…
2016 American Transplant Congress
Outcomes of Ductoplasty in Right Lobe Living Donor Grafts with More Than One Bile Duct.
S. Kapoor, V. Varma, B. Nath, V. Kumaran.
Liver Transplantation & HPB Surgery, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai, Maharashtra, India.
Background:Biliary complications remain the Achilles's heel of LDLT, especially in the setting of multiple ducts in the right lobe graft. Hilar plate glissonian sheath preservation…
2016 American Transplant Congress
The Effect of Families on Organ Donation Among Native Americans.
T. Bongiovanni,^1,3 J. Rawlings,² J. Trompeta.¹
¹Dept of Surgery, UCSF, San Francisco, CA; ²CT Native American Tribal Council, New Haven, CT; ³Robert Wood Johnson Foundation CSP, Yale University School of Medicine, New Haven, CT.
Background: Prevalence of end-stage renal disease is 3.5 times greater among the >2.5 million Native Americans (NAs) in the US than in Caucasians, due to…
2016 American Transplant Congress
Clinical Usefulness of mRECIST Response to Chemoembolization for Recurrence Prediction of Hepatocellular Carcinoma in Living Donor Liver Transplantation.
C. Cho, K. Kim, S. Kim, J. Lee, J. Lee, J. Kim, G.-S. Choi, C. Kwon, J.-W. Joh, N. Lee.
Surgery, Samsung Medical Center, Seoul, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Background Predicting risk for recurrence of hepatocellular carcinoma (HCC) following living donor liver transplantation (LDLT) is clinically important.Methods We performed a retrospective study for assessment…
2016 American Transplant Congress
Prospective Investigation of the Reliability and Validity of the Live Donor Assessment Tool (LDAT).
D. LaPointe Rudow, A. Shenoy, J. Hunt, Z. Filipovic-Jewell, B. Haydel, B. Iacoviello.
Recanati Miller Transplantation Institute, Mount Sinai Hospital, New York, NY.
Purpose: The LDAT was the first psychosocial assessment instrument developed to standardize the live donor (LD) psychosocial evaluation (PsychE). Previously, it was found to be…
2015 American Transplant Congress
Living Donor Liver Transplantation for Biliary Atresia has Equivalent Survival and Shorter Waiting Time Compared to Deceased Donor Liver Transplantation
S. Alexopoulos,¹ V. Nekrasov,¹ L. Matsuoka,¹ K. Chouliaras,² Y. Genyk.¹
¹Department of Surgery, Keck Medical Center of USC, Los Angeles, CA; ²Department of Surgery, Wake Forest University, Winston-Salem, NC.
Purpose: To determine the benefit of living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) in the treatment of end stage liver…
2015 American Transplant Congress
Systematic Medical Record Review to Identify Safety Risks in Living Liver Donors
B. Platt,⁵ D. Woods,⁵ R. Fisher,² J. Guarrera,³ E. Pomfret,⁴ M. Simpson,⁴ A. Daud,¹ T. Curtis,⁵ E. Reyes,⁵ E. Wymore,⁵ A. Skaro,¹ D. Ladner.¹
¹Northwestern University, Chicago, IL; ²Virginia Commonwealth University, Richmond, VA; ³Columbia University, New York, NY; ⁴Lahey Clinic, Boston, MA; ⁵CHS, Northwestern University, Chicago, IL.
BACKGROUNDPrevention of adverse events (AEs) is important in Living Donor Liver Transplantation (LDLT), as these are healthy volunteers who undergo a major procedure with no…
2015 American Transplant Congress
Impact of Preoperative MELD Score On Small for Size Syndrome in Living Donor Liver Transplantation
S. Marubashi, A. Tomokuni, Y. Tomimaru, T. Asaoka, H. Wada, H. Eguchi, K. Umeshita, Y. Doki, M. Mori, H. Nagano.
Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
Living donor liver transplantation (LDLT) has been expanded worldwide and the outcome of even adult-to-adult LDLT using left lobe reported to be equivalent to that…
2015 American Transplant Congress
Living Kidney Donation in the Elderly: The United Kingdom Experience
Z. Ahmed,¹ R. Tamburrini,¹ L. Pankhurst,² N. Kessaris,¹ N. Mamode.¹
¹Renal and Pancreatic Transplantation, Guy's Hospital, London, United Kingdom; ²Department of Clinicsl Trials and Statistics, NHS Blood and Transplant, Bristol, United Kingdom.
Introduction: The increasing demand for organs has led many institutions to accept elderly patients onto their living donor programmes. However no large UK based datasets…